626
Views
0
CrossRef citations to date
0
Altmetric
Review

Long Noncoding RNA: a New Contributor and Potential Therapeutic Target in Fibrosis

&
Pages 1233-1241 | Published online: 15 Aug 2017

References

  • Jiang X , TsitsiouE , HerrickSEet al. MicroRNAs and the regulation of fibrosis . FEBS J.277 ( 9 ), 2015 – 2021 ( 2010 ).
  • Mancini ML , SonisST . Mechanisms of cellular fibrosis associated with cancer regimen-related toxicities . Front. Pharmacol.5 , 51 ( 2014 ).
  • Kendall RT , Feghali-BostwickCA . Fibroblasts in fibrosis: novel roles and mediators . Front. Pharmacol.5 , 123 ( 2014 ).
  • Nagalingam RS , SundaresanNR , NoorMet al. Deficiency of cardiomyocyte-specific microRNA-378 contributes to the development of cardiac fibrosis involving a transforming growth factor β (TGFβ1)-dependent paracrine mechanism . J. Biol. Chem.289 , 27199 – 27214 ( 2014 ).
  • Christmann RB , Sampaio-BarrosP , StifanoGet al. Association of interferon- and transforming growth factor β-regulated genes and macrophage activation with systemic sclerosis-related progressive lung fibrosis . Arthritis. Rheumatol.66 , 714 – 725 ( 2014 ).
  • Jiang X , NingQ . Expression profiling of long noncoding RNAs and the dynamic changes of lncRNA-NR024118 and Cdkn1c in angiotensin II-treated cardiac fibroblasts . Int. J. Clin. Exp. Pathol.7 , 1325 – 1336 ( 2014 ).
  • Jiang X , ZhangF , NingQ . Losartan reverses the down-expression of long noncoding RNA NR024118 and Cdkn1c induced by angiotensin II in adult rat cardiac fibroblasts . Pathol. Biol. (Paris).63 , 122 – 125 ( 2015 ).
  • Khorkova O , HsiaoJ , WahlestedtC . Basic biology and therapeutic implications of lncRNA . Adv. Drug. Deliv. Rev.87 , 15 – 24 ( 2015 ).
  • Batista PJ , ChangHY . Long noncoding RNAs: cellular address codes in development and disease . Cell152 , 1298 – 1307 ( 2013 ).
  • Wahlestedt C . Targeting long non-coding RNA to therapeutically upregulate gene expression . Nat. Rev. Drug Discov.12 , 433 – 446 ( 2013 ).
  • Imamura K , ImamachiN , AkizukiGet al. Long noncoding RNA NEAT1-dependent SFPQ relocation from promoter region to paraspeckle mediates IL8 expression upon immune stimuli . Mol. Cell53 , 393 – 406 ( 2014 ).
  • Lam MT , LiW , RosenfeldMGet al. Enhancer RNAs and regulated transcriptional programs . Trends. Biochem. Sci.39 , 170 – 182 ( 2014 ).
  • Mercer TR , MattickJS . Structure and function of long noncoding RNAs in epigenetic regulation . Nat. Struct. Mol. Biol.20 , 300 – 307 ( 2013 ).
  • Tay Y , RinnJ , PandolfiPP . The multilayered complexity of ceRNA crosstalk and competition . Nature505 , 344 – 352 ( 2014 ).
  • Slavoff SA , MitchellAJ , SchwaidAGet al. Peptidomic discovery of short open reading frame-encoded peptides in human cells . Nat. Chem. Biol.9 , 59 – 64 ( 2013 ).
  • Jiang X , LeiR , NingQ . Circulating long noncoding RNAs as novel biomarkers of human diseases . Biomark. Med.10 ( 7 ), 757 – 769 ( 2016 ).
  • Cao G , ZhangJ , WangMet al. Differential expression of long non-coding RNAs in bleomycin-induced lung fibrosis . Int. J. Mol. Med.32 , 355 – 364 ( 2013 ).
  • Song X , CaoG , JingLet al. Analysing the relationship between lncRNA and protein-coding gene and the role of lncRNA as ceRNA in pulmonary fibrosis . J. Cell. Mol. Med.18 , 991 – 1003 ( 2014 ).
  • Huang C , YangY , LiuL . Interaction of long noncoding RNAs and microRNAs in the pathogenesis of idiopathic pulmonary fibrosis . Physiol. Genomics47 ( 10 ), 463 – 469 ( 2015 ).
  • Sun H , ChenJ , QianWet al. Integrated long non-coding RNA analyses identify novel regulators of epithelial-mesenchymal transition in the mouse model of pulmonary fibrosis . J. Cell Mol. Med.20 , 1234 – 1246 ( 2016 ).
  • Zhou WQ , WangP , ShaoQPet al. Lipopolysaccharide promotes pulmonary fibrosis in acute respiratory distress syndrome (ARDS) via lincRNA-p21 induced inhibition of Thy-1 expression . Mol. Cell Biochem.419 , 19 – 28 ( 2016 ).
  • Wu Q , HanL , YanWet al. miR-489 inhibits silica-induced pulmonary fibrosis by targeting MyD88 and Smad3 and is negatively regulated by lncRNA CHRF . Sci. Rep.6 , 30921 ( 2016 ).
  • Tang Y , HeR , AnJet al. The effect of H19-miR-29b interaction on bleomycin-induced mouse model of idiopathic pulmonary fibrosis . Biochem. Biophys. Res. Commun.479 ( 3 ), 417 – 423 ( 2016 ).
  • He Y , WuYT , HuangCet al. Inhibitory effects of long noncoding RNA MEG3 on hepatic stellate cells activation and liver fibrogenesis . Biochim. Biophys. Acta1842 , 2204 – 2215 ( 2014 ).
  • Zhang QQ , XuMY , QuYet al. TET3 mediates the activation of human hepatic stellate cells via modulating the expression of long non-coding RNA HIF1A-AS . Int. J. Clin. Exp. Pathol.7 , 7744 – 7751 ( 2014 ).
  • Yu F , ZhengJ , MaoYet al. Long non-coding RNA APTR promotes the activation of hepatic stellate cells and the progression of liver fibrosis . Biochem. Biophys. Res. Commun.463 , 679 – 685 ( 2015 ).
  • Zheng J , DongP , MaoYet al. lincRNA-p21 inhibits hepatic stellate cell activation and liver fibrogenesis via p . FEBS. J.282 ( 24 ), 4810 – 4821 ( 2015 ).
  • Yu F , LuZ , ChenBet al. Identification of a novel lincRNA–p21–miR-181b–PTEN signaling cascade in liver fibrosis . Mediators. Inflamm. 2016 , 9856538 ( 2016 ).
  • Yu F , GuoY , ChenBet al. LincRNA-p21 inhibits the Wnt/β-catenin pathway in activated hepatic stellate cells via sponging microRNA-17–5p . Cell Physiol. Biochem.41 , 1970 – 1980 ( 2017 ).
  • Yu F , ZhengJ , MaoYet al. Long non-coding RNA growth arrest-specific transcript 5 (GAS5) inhibits liver fibrogenesis through a mechanism of competing endogenous RNA . J. Biol. Chem.290 ( 47 ), 28286 – 28298 ( 2015 ).
  • Yu F , LuZ , CaiJet al. MALAT1 functions as a competing endogenous RNA to mediate Rac1 expression by sequestering miR-101b in liver fibrosis . Cell Cycle14 ( 24 ), 3885 – 3896 ( 2015 ).
  • Zheng J , YuF , DongPet al. Long non-coding RNA PVT1 activates hepatic stellate cells through competitively binding microRNA- Oncotarget 7 , 62886 – 62897 ( 2016 ).
  • Yu F , ChenB , DongPet al. HOTAIR epigenetically modulates PTEN expression via microRNA-29b: a novel mechanism in regulation of liver fibrosis . Mol. Ther.25 , 205 – 217 ( 2017 ).
  • Bian EB , WangYY , YangYet al. Hotair facilitates hepatic stellate cells activation and fibrogenesis in the liver . Biochim. Biophys. Acta1863 , 674 – 686 ( 2017 ).
  • Fu N , ZhaoSX , KongLBet al. LncRNA-ATB/microRNA-200a/β-catenin regulatory axis involved in the progression of HCV-related hepatic fibrosis . Gene618 , 1 – 7 ( 2017 ).
  • Yang JJ , LiuLP , TaoHet al. MeCP2 silencing of LncRNA H19 controls hepatic stellate cell proliferation by targeting IGF1R . Toxicology359–360 , 39 – 46 ( 2016 ).
  • Li X , LiuR , YangJet al. The role of long noncoding RNA H19 in gender disparity of cholestatic liver injury in multidrug resistance 2 gene knockout mice . Hepatology doi:10.1002/hep.29145 ( 2017 ) ( Epub ahead of print ).
  • Song Y , LiuC , LiuXet al. H19 promotes cholestatic liver fibrosis by preventing ZEB1-mediated inhibition of EpCAM . Hepatology doi:10.1002/hep.29209 ( 2017 ) ( Epub ahead of print ).
  • Zhou Q , ChungAC , HuangXRet al. Identification of novel long noncoding RNAs associated with TGF-β/Smad3-mediated renal inflammation and fibrosis by RNA sequencing . Am. J. Pathol.184 , 409 – 417 ( 2014 ).
  • Zhou Q , HuangXR , YuJWet al. Long non-coding RNA Arid2-IR is a novel therapeutic target for renal inflammation . Mol. Ther.23 , 1034 – 1043 ( 2015 ).
  • Wang M , WangS , YaoDet al. A novel long non-coding RNA CYP4B1-PS1–001 regulates proliferation and fibrosis in diabetic nephropathy . Mol. Cell. Endocrinol.426 , 136 – 145 ( 2016 ).
  • Xie H , XueJD , ChaoFet al. Long non-coding RNA-H19 antagonism protects against renal fibrosis . Oncotarget7 , 51473 – 51481 ( 2016 ).
  • Wang M , YaoD , WangSet al. Long non-coding RNA ENSMUST00000147869 protects mesangial cells from proliferation and fibrosis induced by diabetic nephropathy . Endocrine54 , 81 – 92 ( 2016 ).
  • Yi H , PengR , ZhangLYet al. LincRNA-Gm4419 knockdown ameliorates NF-κB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy . Cell Death Dis.8 , e2583 ( 2017 ).
  • Gao Y , ChenZY , WangYet al. Long non-coding RNA ASncmtRNA-2 is upregulated in diabetic kidneys and high glucose-treated mesangial cells . Exp. Ther. Med.13 , 581 – 587 ( 2017 ).
  • Wang K , LiuF , ZhouLYet al. The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR . Circ. Res.114 ( 9 ), 1377 – 1388 ( 2014 ).
  • Han P , LiW , LinCHet al. A long noncoding RNA protects the heart from pathological hypertrophy . Nature514 ( 7520 ), 102 – 106 ( 2014 ).
  • Williams SM , Golden-MasonL , FergusonBSet al. Class I HDACs regulate angiotensin II-dependent cardiac fibrosis via fibroblasts and circulating fibrocytes . J. Mol. Cell. Cardiol.67 , 112 – 125 ( 2014 ).
  • Jiang X , NingQ , WangJ . Angiotensin II induced differentially expressed microRNAs in adult rat cardiac fibroblasts . J. Physiol. Sci.63 , 31 – 38 ( 2013 ).
  • Eskildsen TV , SchneiderM , SandbergMBet al. The microRNA-132/212 family fine-tunes multiple targets in Angiotensin II signalling in cardiac fibroblasts . J. Renin. Angiotensin. Aldosterone. Syst.16 ( 4 ), 1288 – 1297 ( 2015 ).
  • Jiang X , NingQ . The emerging roles of long noncoding RNAs in common cardiovascular diseases . Hypertens. Res.38 , 375 – 379 ( 2015 ).
  • Qu X , SongX , YuanWet al. Expression signature of lncRNAs and their potential roles in cardiac fibrosis of post-infarct mice . BioSci. Rep.36 ( 3 ), pii:e00337 ( 2016 ).
  • Huang ZP , DingY , ChenJet al. Long non-coding RNAs link extracellular matrix gene expression to ischemic cardiomyopathy . Cardiovasc. Res. doi:10.1093/cvr/cvw201 , pii:cvw201 ( 2016 ) ( Epub ahead of print ).
  • Tao H , CaoW , YangJJet al. Long noncoding RNA H19 controls DUSP5/ERK1/2 axis in cardiac fibroblast proliferation and fibrosis . Cardiovasc. Pathol.25 ( 5 ), 381 – 389 ( 2016 ).
  • Tao H , ZhangJG , QinRHet al. LncRNA GAS5 controls cardiac fibroblast activation and fibrosis by targeting miR-21 via PTEN/MMP-2 signaling pathway . Toxicology386 , 11 – 18 ( 2017 ).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.